{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:36:19Z","timestamp":1789000579646,"version":"build-2803163510"},"reference-count":96,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T00:00:00Z","timestamp":1721260800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>The triglyceride\u2013glucose (TyG) index, proven to be a crucial insulin resistance biomarker (better than the Homeostasis Model Assessment for Insulin Resistance), is simple and non-invasive. Recently, indisputable evidence has shown that the TyG index is strongly associated with cardiovascular disease [CVD, including atherosclerosis, heart failure (HF), and hypertension] prognosis and mortality. Nevertheless, the value of the TyG index in HF patients treated with sodium\u2013glucose cotransporter 2 inhibitors (SGLT2is) has not been systematically evaluated. Therefore, in this review, we summarized the value of the TyG index and its related parameters as markers of CVD, especially HF. Furthermore, we addressed the use of SGLT2is and GLP-1 receptor antagonists in HF patients. Finally, we summarized the mechanism of the \u201cobesity paradox.\u201d<\/jats:p>","DOI":"10.3389\/fcvm.2024.1397907","type":"journal-article","created":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T04:56:01Z","timestamp":1721278561000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Value of the triglyceride\u2013glucose index and related parameters in heart failure patients"],"prefix":"10.3389","volume":"11","author":[{"given":"Yunteng","family":"Fang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingchun","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,7,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e895","DOI":"10.1161\/CIR.0000000000001063","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1001\/jama.2020.13310","article-title":"Heart failure","volume":"324","author":"Baman","year":"2020","journal-title":"JAMA"},{"key":"B3","doi-asserted-by":"publisher","first-page":"3272","DOI":"10.1093\/cvr\/cvac013","article-title":"Global burden of heart failure: a comprehensive and updated review of epidemiology","volume":"118","author":"Savarese","year":"2023","journal-title":"Cardiovasc Res"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e008406","DOI":"10.1161\/CIRCHEARTFAILURE.121.008406","article-title":"Prevalence and incidence of heart failure among urban patients in China: a national population-based analysis","volume":"14","author":"Wang","year":"2021","journal-title":"Circ Heart Fail"},{"key":"B5","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.jchf.2017.12.006","article-title":"Innovation in heart failure treatment: life expectancy, disability, and health disparities","volume":"6","author":"Van Nuys","year":"2018","journal-title":"JACC Heart Fail"},{"key":"B6","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1002\/ejhf.2848","article-title":"Natriuretic peptides: role in the diagnosis and management of heart failure: a scientific statement from the Heart Failure Association of the European Society of Cardiology, Heart Failure Society of America and Japanese Heart Failure Society","volume":"25","author":"Tsutsui","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"B7","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1002\/ehf2.12486","article-title":"Cardiovascular biomarkers predict post-discharge re-hospitalization risk and mortality among Swedish heart failure patients","volume":"6","author":"Molvin","year":"2019","journal-title":"ESC Heart Fail"},{"key":"B8","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/s12933-023-01971-9","article-title":"Association between the triglyceride glucose (TyG) index and the risk of acute kidney injury in critically ill patients with heart failure: analysis of the MIMIC-IV database","volume":"22","author":"Yang","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12933-021-01268-9","article-title":"Triglyceride\u2013glucose index and the incidence of atherosclerotic cardiovascular diseases: a meta-analysis of cohort studies","volume":"20","author":"Ding","year":"2021","journal-title":"Cardiovasc Diabetol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s12933-023-01918-0","article-title":"Triglyceride-glucose index is associated with the occurrence and prognosis of cardiac arrest: a multicenter retrospective observational study","volume":"22","author":"Boshen","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.3906\/sag-2006-180","article-title":"The triglyceride-glucose index predicts peripheral artery disease complexity","volume":"50","author":"Duran Karaduman","year":"2020","journal-title":"Turk J Med Sci"},{"key":"B12","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1186\/s12933-023-02001-4","article-title":"High triglyceride-glucose (TyG) index is associated with poor prognosis of heart failure with preserved ejection fraction","volume":"22","author":"Zhou","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s12933-023-02030-z","article-title":"The triglyceride-glucose index is a predictor for cardiovascular and all-cause mortality in CVD patients with diabetes or pre-diabetes: evidence from NHANES 2001\u20132018","volume":"22","author":"Zhang","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1086978","DOI":"10.3389\/fcvm.2023.1086978","article-title":"Triglyceride-glucose index for the detection of subclinical heart failure with preserved ejection fraction in patients with type 2 diabetes","volume":"10","author":"Wang","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"111818","DOI":"10.1016\/j.mad.2023.111818","article-title":"miR-181c targets Parkin and SMAD7 in human cardiac fibroblasts: validation of differential microRNA expression in patients with diabetes and heart failure with preserved ejection fraction","volume":"212","author":"Jankauskas","year":"2023","journal-title":"Mech Ageing Dev"},{"key":"B16","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jjcc.2023.06.008","article-title":"Insulin resistance is associated with subclinical myocardial dysfunction and reduced functional capacity in heart failure with preserved ejection fraction","volume":"83","author":"Gudenkauf","year":"2024","journal-title":"J Cardiol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"742178","DOI":"10.3389\/fcvm.2021.742178","article-title":"Inflammation in metabolic cardiomyopathy","volume":"8","author":"Wenzl","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s12902-023-01449-5","article-title":"Triglyceride-glucose index and cervical vascular function: outpatient-based cohort study","volume":"23","author":"Pan","year":"2023","journal-title":"BMC Endocr Disord"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1111\/jdi.13573","article-title":"Insulin resistance surrogates predict hypertension plus hyperuricemia","volume":"12","author":"Li","year":"2021","journal-title":"J Diabetes Investig"},{"key":"B20","doi-asserted-by":"publisher","first-page":"m4573","DOI":"10.1136\/bmj.m4573","article-title":"Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials","volume":"372","author":"Palmer","year":"2021","journal-title":"Br Med J"},{"key":"B21","doi-asserted-by":"publisher","first-page":"102581","DOI":"10.1016\/j.dsx.2022.102581","article-title":"Challenges in the diagnosis of insulin resistance: focusing on the role of HOMA-IR and tryglyceride\/glucose index","volume":"16","author":"Tahapary","year":"2022","journal-title":"Diabetes Metab Syndr"},{"key":"B22","doi-asserted-by":"publisher","first-page":"876","DOI":"10.3390\/medicina58070876","article-title":"TyG index performs better than HOMA-IR in Chinese type 2 diabetes mellitus with a BMI <35kg\/m2: a hyperglycemic clamp validated study","volume":"58","author":"Luo","year":"2022","journal-title":"Medicina (Kaunas)"},{"key":"B23","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s12933-021-01274-x","article-title":"Stronger association of triglyceride glucose index than the HOMA-IR with arterial stiffness in patients with type 2 diabetes: a real-world single-centre study","volume":"20","author":"Wang","year":"2021","journal-title":"Cardiovasc Diabetol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"109042","DOI":"10.1016\/j.diabres.2021.109042","article-title":"The triglyceride\u2013glucose index is a more powerful surrogate marker for predicting the prevalence and incidence of type 2 diabetes mellitus than the homeostatic model assessment of insulin resistance","volume":"180","author":"Park","year":"2021","journal-title":"Diabetes Res Clin Pract"},{"key":"B25","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.numecd.2021.11.017","article-title":"Comparison of triglyceride-glucose index and HOMA-IR for predicting prevalence and incidence of metabolic syndrome","volume":"32","author":"Son","year":"2022","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"B26","doi-asserted-by":"publisher","first-page":"944258","DOI":"10.3389\/fcvm.2022.944258","article-title":"Triglyceride-glucose index and homeostasis model assessment-insulin resistance in young adulthood and risk of incident congestive heart failure in midlife: the coronary artery risk development in young adults study","volume":"9","author":"Zeng","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s12933-022-01638-x","article-title":"Association between triglyceride glucose index and atherosclerotic plaques and burden: findings from a community-based study","volume":"21","author":"Wang","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1093\/eurjpc\/zwad173","article-title":"Insulin resistance drives cognitive impairment in hypertensive pre-diabetic frail elders: the CENTENNIAL study","volume":"30","author":"Mone","year":"2023","journal-title":"Eur J Prev Cardiol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s12933-024-02218-x","article-title":"Frail hypertensive older adults with prediabetes and chronic kidney disease: insights on organ damage and cognitive performance\u2014preliminary results from the CARYATID study","volume":"23","author":"Santulli","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s12944-023-01959-0","article-title":"The association between triglyceride-glucose index and cognitive function in nondiabetic elderly: NHANES 2011\u20132014","volume":"22","author":"Wei","year":"2023","journal-title":"Lipids Health Dis"},{"key":"B31","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1111\/andr.13207","article-title":"The triglycerides and glucose index is not superior to HOMA-IR in predicting testosterone deficiency among adult males","volume":"11","author":"Liu","year":"2023","journal-title":"Andrology"},{"key":"B32","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13098-023-01009-w","article-title":"Association of triglyceride-glucose index with atherosclerotic cardiovascular disease and mortality among familial hypercholesterolemia patients","volume":"15","author":"Wen","year":"2023","journal-title":"Diabetol Metab Syndr"},{"key":"B33","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s12933-023-01895-4","article-title":"Association between the triglyceride\u2013glucose index and the risk of mortality among patients with chronic heart failure: results from a retrospective cohort study in China","volume":"22","author":"Zhou","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12933-023-01864-x","article-title":"Association between triglyceride-glucose index and all-cause mortality in critically ill patients with ischemic stroke: analysis of the MIMIC-IV database","volume":"22","author":"Cai","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s12933-022-01563-z","article-title":"Triglyceride-glucose index linked to all-cause mortality in critically ill patients: a cohort of 3026 patients","volume":"21","author":"Liao","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12933-023-01737-3","article-title":"Independent effects of the triglyceride-glucose index on all-cause mortality in critically ill patients with coronary heart disease: analysis of the MIMIC-III database","volume":"22","author":"Zhang","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1186\/s12933-023-02054-5","article-title":"Association of triglyceride glucose index with all-cause and cardiovascular mortality in the general population","volume":"22","author":"Chen","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12933-022-01732-0","article-title":"The impact of triglyceride-glucose index on ischemic stroke: a systematic review and meta-analysis","volume":"22","author":"Yang","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/s41392-023-01400-z","article-title":"Diabetic vascular diseases: molecular mechanisms and therapeutic strategies","volume":"8","author":"Li","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/clinem\/dgae170","article-title":"Triglyceride-glucose index and mortality in a large regional-based Italian database (URRAH project)","author":"D'Elia","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"B41","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12933-018-0762-4","article-title":"Association between insulin resistance and the development of cardiovascular disease","volume":"17","author":"Ormazabal","year":"2018","journal-title":"Cardiovasc Diabetol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12933-022-01546-0","article-title":"Relationship between the triglyceride-glucose index and risk of cardiovascular diseases and mortality in the general population: a systematic review and meta-analysis","volume":"21","author":"Liu","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/j.jchf.2022.08.007","article-title":"Influence of NT-proBNP on efficacy of dapagliflozin in heart failure with mildly reduced or preserved ejection fraction","volume":"10","author":"Myhre","year":"2022","journal-title":"JACC Heart Fail"},{"key":"B44","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1186\/s12933-022-01671-w","article-title":"NT-ProBNP and mortality across the spectrum of glucose tolerance in the general US population","volume":"21","author":"Ciardullo","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.jchf.2020.08.008","article-title":"N-terminal pro-B-type natriuretic peptide and clinical outcomes","volume":"8","author":"Ezekowitz","year":"2020","journal-title":"JACC: Heart Failure"},{"key":"B46","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.jchf.2022.04.015","article-title":"Sequential evaluation of NT-proBNP in heart failure: insights into clinical outcomes and efficacy of vericiguat","volume":"10","author":"Armstrong","year":"2022","journal-title":"JACC Heart Fail"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1016\/j.jacc.2021.07.045","article-title":"NT-proBNP response to heart failure therapies","volume":"78","author":"Cunningham","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.3390\/jpm13071155","article-title":"Mid-regional pro-adrenomedullin and N-terminal pro-B-type natriuretic peptide measurement: a multimarker approach to diagnosis and prognosis in acute heart failure","volume":"13","author":"Spoto","year":"2023","journal-title":"J Pers Med"},{"key":"B49","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1136\/hrt.2010.210948","article-title":"Prognostic value of mid-regional pro-adrenomedullin in patients with heart failure after an acute myocardial infarction","volume":"97","author":"Klip","year":"2011","journal-title":"Heart"},{"key":"B50","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1007\/s00125-018-4727-7","article-title":"Prognostic value of plasma MR-proADM vs NT-proBNP for heart failure in people with type 2 diabetes: the SURDIAGENE prospective study","volume":"61","author":"Fraty","year":"2018","journal-title":"Diabetologia"},{"key":"B51","doi-asserted-by":"publisher","first-page":"e13246","DOI":"10.1111\/eci.13246","article-title":"MR-proADM to detect specific types of organ failure in infection","volume":"50","author":"Andr\u00e9s","year":"2020","journal-title":"Eur J Clin Invest"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.3390\/medicina58101477","article-title":"Relation between mid-regional pro-adrenomedullin in patients with chronic heart failure and the dose of diuretics in 2-year follow-up-data from FAR NHL registry","volume":"58","author":"\u0160pinarov\u00e1","year":"2022","journal-title":"Medicina (Kaunas)"},{"key":"B53","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s00059-018-4702-6","article-title":"Diagnostic value of novel biomarkers for heart failure: a meta-analysis","volume":"45","author":"Huang","year":"2020","journal-title":"Herz"},{"key":"B54","doi-asserted-by":"publisher","first-page":"950338","DOI":"10.3389\/fnut.2022.950338","article-title":"Triglyceride glucose index and its combination with the get with the guidelines-heart failure score in predicting the prognosis in patients with heart failure","volume":"9","author":"Han","year":"2022","journal-title":"Front Nutr"},{"key":"B55","doi-asserted-by":"publisher","first-page":"103","DOI":"10.17219\/acem\/166043","article-title":"The triglyceride glucose index predicts short-term mortality in non-diabetic patients with acute heart failure","volume":"33","author":"Cheng","year":"2024","journal-title":"Adv Clin Exp Med"},{"key":"B56","doi-asserted-by":"publisher","first-page":"487","DOI":"10.2217\/bmm-2023-0113","article-title":"Admission triglyceride-glucose index is predictor of long-term mortality and appropriate implantable cardiac defibrillator therapy in patients with heart failure","volume":"17","author":"\u00d6zcan","year":"2023","journal-title":"Biomark Med"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1100399","DOI":"10.3389\/fendo.2023.1100399","article-title":"Prognostic significance of the triglyceride-glucose index for patients with ischemic heart failure after percutaneous coronary intervention","volume":"14","author":"Sun","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B58","doi-asserted-by":"publisher","first-page":"108786","DOI":"10.1016\/j.diabres.2021.108786","article-title":"The prognostic value of the triglyceride glucose index in patients with chronic heart failure and type 2 diabetes: a retrospective cohort study","volume":"177","author":"Guo","year":"2021","journal-title":"Diabetes Res Clin Pract"},{"key":"B59","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/s12933-023-01967-5","article-title":"Relationship between cumulative exposure to triglyceride-glucose index and heart failure: a prospective cohort study","volume":"22","author":"Zheng","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1186\/s12872-023-03294-9","article-title":"Prevalence estimates of the insulin resistance and associated prevalence of heart failure among united Status adults","volume":"23","author":"Li","year":"2023","journal-title":"BMC Cardiovasc Disord"},{"key":"B61","doi-asserted-by":"publisher","first-page":"10742484231181846","DOI":"10.1177\/10742484231181846","article-title":"The prognostic value of the triglyceride glucose Index in patients with acute myocardial infarction","volume":"28","author":"Hao","year":"2023","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"B62","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1186\/s12933-022-01680-9","article-title":"Association between triglyceride glucose index and worsening heart failure in significant secondary mitral regurgitation following percutaneous coronary intervention","volume":"21","author":"Huang","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s12933-022-01658-7","article-title":"Triglyceride-glucose index and the risk of heart failure: evidence from two large cohorts and a Mendelian randomization analysis","volume":"21","author":"Li","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"101246","DOI":"10.1016\/j.diabet.2021.101246","article-title":"Elevated triglyceride-glucose index predicts risk of incident ischaemic stroke: the rural Chinese cohort study","volume":"47","author":"Zhao","year":"2021","journal-title":"Diabetes Metab"},{"key":"B65","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/S0140-6736(20)31824-9","article-title":"SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-reduced and DAPA-HF trials","volume":"396","author":"Zannad","year":"2020","journal-title":"Lancet"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1056\/NEJMoa2206286","article-title":"Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction","volume":"387","author":"Solomon","year":"2022","journal-title":"N Engl J Med"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1161\/CIRCULATIONAHA.121.056824","article-title":"Effect of empagliflozin on worsening heart failure events in patients with heart failure and preserved ejection fraction: EMPEROR-preserved trial","volume":"144","author":"Packer","year":"2021","journal-title":"Circulation"},{"key":"B68","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1161\/CIRCULATIONAHA.122.059785","article-title":"Empagliflozin for heart failure with preserved left ventricular ejection fraction with and without diabetes","volume":"146","author":"Filippatos","year":"2022","journal-title":"Circulation"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N Engl J Med"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1161\/CIRCULATIONAHA.122.059755","article-title":"Effects of empagliflozin in women and men with heart failure and preserved ejection fraction","volume":"146","author":"Butler","year":"2022","journal-title":"Circulation"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1056\/NEJMoa2004967","article-title":"Cardiovascular outcomes with ertugliflozin in type 2 diabetes","volume":"383","author":"Cannon","year":"2020","journal-title":"N Engl J Med"},{"key":"B72","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s12933-022-01627-0","article-title":"Effect of dapagliflozin on the prognosis of patients with acute myocardial infarction undergoing percutaneous coronary intervention","volume":"21","author":"Zhu","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"295","DOI":"10.23736\/S2724-6507.21.03465-5","article-title":"SGLT2 inhibitors improve plasma atherogenic biomarkers in patients with type 2 diabetes: a real-world retrospective observational study","volume":"48","author":"Imre","year":"2023","journal-title":"Minerva Endocrinol (Torino)"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1007\/s13300-021-01056-4","article-title":"One year of dapaglifozin add-on therapy ameliorates surrogate indexes of insulin resistance and adiposity in patients with type 2 diabetes mellitus","volume":"12","author":"Radellini","year":"2021","journal-title":"Diabetes Ther"},{"key":"B75","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/S2213-8587(21)00203-5","article-title":"Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials","volume":"9","author":"Sattar","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1007\/s40265-023-01932-2","article-title":"Clinical outcomes with GLP-1 receptor agonists in patients with heart failure: a systematic review and meta-analysis of randomized controlled trials","volume":"83","author":"Zhao","year":"2023","journal-title":"Drugs"},{"key":"B77","doi-asserted-by":"publisher","first-page":"909","DOI":"10.2337\/dc21-1113","article-title":"Primary prevention of cardiovascular and heart failure events with SGLT2 inhibitors, GLP-1 receptor agonists, and their combination in type 2 diabetes","volume":"45","author":"Wright","year":"2022","journal-title":"Diabetes Care"},{"key":"B78","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41569-023-00849-3","article-title":"Glucagon-like peptide 1 receptor agonists: cardiovascular benefits and mechanisms of action","volume":"20","author":"Ussher","year":"2023","journal-title":"Nat Rev Cardiol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12933-022-01474-z","article-title":"The effect of DPP-4 inhibitors, GLP-1 receptor agonists and SGLT-2 inhibitors on cardiorenal outcomes: a network meta-analysis of 23 CVOTs","volume":"21","author":"Giugliano","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"101602","DOI":"10.1016\/j.cpcardiol.2023.101602","article-title":"The safety and efficacy of GLP-1 receptor agonists in heart failure patients: a systematic review and meta-analysis","volume":"48","author":"Merza","year":"2023","journal-title":"Curr Probl Cardiol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1038\/s41440-023-01502-9","article-title":"The association of triglyceride-glucose index and related parameters with hypertension and cardiovascular risk: a cross-sectional study","volume":"47","author":"Miao","year":"2023","journal-title":"Hypertens Res"},{"key":"B82","doi-asserted-by":"publisher","first-page":"1294909","DOI":"10.3389\/fendo.2023.1294909","article-title":"Association between triglyceride glucose-body mass index and heart failure in subjects with diabetes mellitus or prediabetes mellitus: a cross-sectional study","volume":"14","author":"Yang","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B83","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12933-023-02115-9","article-title":"The association between triglyceride-glucose index and its combination with obesity indicators and cardiovascular disease: NHANES 2003\u20132018","volume":"23","author":"Dang","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1186\/s12933-023-02047-4","article-title":"Association between triglyceride glucose-body mass and one-year all-cause mortality of patients with heart failure: a retrospective study utilizing the MIMIC-IV database","volume":"22","author":"Dou","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.numecd.2023.09.027","article-title":"Effects of triglyceride glucose (TyG) and TyG-body mass index on sex-based differences in the early-onset heart failure of ST-elevation myocardial infarction","volume":"34","author":"Chen","year":"2023","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"B86","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1038\/ijo.2013.203","article-title":"The obesity paradox in heart failure patients with preserved versus reduced ejection fraction: a meta-analysis of individual patient data","volume":"38","author":"Padwal","year":"2014","journal-title":"Int J Obes (Lond)"},{"key":"B87","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1161\/CIRCULATIONAHA.119.045033","article-title":"Implications of altered ketone metabolism and therapeutic ketosis in heart failure","volume":"141","author":"Selvaraj","year":"2020","journal-title":"Circulation"},{"key":"B88","doi-asserted-by":"publisher","first-page":"3054","DOI":"10.1016\/j.jacc.2019.04.022","article-title":"Systolic blood pressure and outcomes in patients with heart failure with reduced ejection fraction","volume":"73","author":"Arundel","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"230","DOI":"10.2174\/0929867326666190325094453","article-title":"Obesity and cardioprotection","volume":"27","author":"Femmin\u00f2","year":"2020","journal-title":"Curr Med Chem"},{"key":"B90","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1253\/circj.CJ-23-0774","article-title":"Heart failure medication and muscle wasting","volume":"88","author":"Izumiya","year":"2023","journal-title":"Circ J"},{"key":"B91","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1186\/s13054-019-2506-6","article-title":"Adipose tissue protects against sepsis-induced muscle weakness in mice: from lipolysis to ketones","volume":"23","author":"Goossens","year":"2019","journal-title":"Crit Care"},{"key":"B92","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1002\/jcsm.12603","article-title":"Muscle wasting as an independent predictor of survival in patients with chronic heart failure","volume":"11","author":"von Haehling","year":"2020","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"B93","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12877-020-01950-9","article-title":"High percent body fat mass predicts lower risk of cardiac events in patients with heart failure: an explanation of the obesity paradox","volume":"21","author":"Ohori","year":"2021","journal-title":"BMC Geriatr"},{"key":"B94","doi-asserted-by":"publisher","first-page":"3576","DOI":"10.1093\/cvr\/cvab368","article-title":"Obesity increases heart failure incidence and mortality: observational and Mendelian randomization studies totalling over 1 million individuals","volume":"118","author":"Benn","year":"2023","journal-title":"Cardiovasc Res"},{"key":"B95","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1007\/s00392-021-01822-1","article-title":"Re-appraisal of the obesity paradox in heart failure: a meta-analysis of individual data","volume":"110","author":"Marcks","year":"2021","journal-title":"Clin Res Cardiol"},{"key":"B96","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1136\/heartjnl-2023-322459","article-title":"Body mass index and survival in people with heart failure","volume":"109","author":"Jones","year":"2023","journal-title":"Heart"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2024.1397907\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T04:56:03Z","timestamp":1721278563000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2024.1397907\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,18]]},"references-count":96,"alternative-id":["10.3389\/fcvm.2024.1397907"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2024.1397907","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,18]]},"article-number":"1397907"}}